Professional Bio
Brian I. Rini, MD, FASCO, is the Chief of Clinical Trials at Vanderbilt-Ingram Cancer Center (VICC) and Ingram Professor of Medicine at Vanderbilt University, where he leads kidney cancer clinical research efforts and the expansion of cancer clinical research operations.
His research activities include over 300 publications extensively covering genitourinary cancer, most notably renal cell carcinoma. Dr. Rini has been lead investigator of several phase 3 clinical trials which have led to FDA approval. He has spoken at numerous seminars and invited lectureships, locally, nationally, and internationally, on genitourinary cancers and their treatments.
Dr. Rini is a member of ASCO, KCA (Kidney Cancer Association) and SITC (Society for Immunotherapy of Cancer) with leadership positions in these organizations. He recently completed a term as a member and immediate past Chair of the Oncologic Drugs Advisory Committee (ODAC).
Relevant Links
Publications
Education
MD - The Ohio State University, 1995
Residency - Internal Medicine - University of Chicago, 1998
Fellowship - Hematology/Oncology - University of Chicago, 2001
Contact
Email
Kimryn.Rathmell@Vumc.Org
Address
777 Preston Research Building
2220 Pierce Ave
Nashville, TN 37232-6307